Thus, mdx/utrophin-heterozygous mice may be a more useful DMD model for a further study to evaluate a longer-term treatment of IL-6R blockade, particularly on analyzing muscle function, a time course change in inflammatory response, and the survival curve [49, 50]. The gene discussed is IL6R; the disease is Duchenne muscular dystrophy.